Rezolute (RZLT) Capital Expenditures (2013 - 2022)

Rezolute recorded quarterly Capital Expenditures of $83000.0 in Q4 2022, up 18.57% quarter-over-quarter from $70000.0 in Q3 2022.

Rezolute's Capital Expenditures history runs 8 years deep, the most recent figure standing at $83000.0 for Q4 2022.

  • In Q4 2022, Capital Expenditures changed N/A year-over-year to $83000.0; the TTM figure through Jun 2023 stood at $153000.0 (changed N/A YoY), while the FY2023 annual figure was $153000.0, changed N/A from the prior year.
  • Capital Expenditures came in at $83000.0 for Q4 2022 at Rezolute, up from $70000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $83000.0 in Q4 2022 to a low of $184.0 in Q2 2018.
  • A 3-year average of $40036.8 and a median of $41000.0 in 2019 frame the typical range for Capital Expenditures.
  • Across the five-year window, Capital Expenditures sank 99.83% in 2018 and jumped 3160.87% in 2019, its largest moves.
  • Rezolute's Capital Expenditures stood at $184.0 in 2018, then surged by 3160.87% to $6000.0 in 2019, then surged by 1283.33% to $83000.0 in 2022.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $83000.0, $70000.0, and $6000.0 for Q4 2022, Q3 2022, and Q2 2019 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 133.40 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 230.60 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 21.83 Mn
10 Rezolute 374.41 Mn 374.41 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 83,000.00
Dec 31, 2022 83,000.00
Sep 30, 2022 70,000.00
Sep 30, 2022 70,000.00
Jun 30, 2019 6,000.00
Jun 30, 2019 6,000.00
Mar 31, 2019 41,000.00
Mar 31, 2019 41,000.00
Jun 30, 2018 184.00
Jun 30, 2018 184.00
Sep 30, 2017 5,816.00
Sep 30, 2017 5,816.00
Jun 30, 2017 107,627.00
Jun 30, 2017 107,627.00
Mar 31, 2017 27,715.00
Mar 31, 2017 27,715.00
Dec 31, 2016 145,631.00
Dec 31, 2016 145,631.00
Sep 30, 2016 126,956.00
Sep 30, 2016 126,956.00
Jun 30, 2016 317,377.00
Jun 30, 2016 317,377.00
Mar 31, 2016 516,871.00
Mar 31, 2016 516,871.00
Dec 31, 2015 681,271.00
Dec 31, 2015 681,271.00
Sep 30, 2015 576,271.00
Sep 30, 2015 576,271.00
Jun 30, 2015 2.23 Mn
Jun 30, 2015 2.23 Mn
Mar 31, 2015 608,916.00
Mar 31, 2015 608,916.00
Dec 31, 2014 98,007.00
Dec 31, 2014 98,007.00
Sep 30, 2014 168,037.00
Sep 30, 2014 168,037.00
Jun 30, 2014 69,974.00
Jun 30, 2014 69,974.00
Mar 31, 2013 11,717.00
Mar 31, 2013 11,717.00